HomeCompareHPTO vs JNJ

HPTO vs JNJ: Dividend Comparison 2026

HPTO yields 1104.97% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HPTO wins by $45232126.13M in total portfolio value
10 years
HPTO
HPTO
● Live price
1104.97%
Share price
$0.18
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45232126.16M
Annual income
$38,396,504,124,252.64
Full HPTO calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — HPTO vs JNJ

📍 HPTO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHPTOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HPTO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HPTO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HPTO
Annual income on $10K today (after 15% tax)
$93,922.65/yr
After 10yr DRIP, annual income (after tax)
$32,637,028,505,614.74/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, HPTO beats the other by $32,637,028,501,628.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HPTO + JNJ for your $10,000?

HPTO: 50%JNJ: 50%
100% JNJ50/50100% HPTO
Portfolio after 10yr
$22616063.10M
Annual income
$19,198,252,064,471.02/yr
Blended yield
84.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HPTO
No analyst data
Altman Z
-14.9
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HPTO buys
0
JNJ buys
0
No recent congressional trades found for HPTO or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHPTOJNJ
Forward yield1104.97%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$45232126.16M$30.3K
Annual income after 10y$38,396,504,124,252.64$4,689.40
Total dividends collected$44716820.88M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HPTO vs JNJ ($10,000, DRIP)

YearHPTO PortfolioHPTO Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$121,197$110,497.24$10,592$272.30+$110.6KHPTO
2$1,381,266$1,251,585.04$11,289$357.73+$1.37MHPTO
3$14,808,908$13,330,953.52$12,123$472.89+$14.80MHPTO
4$149,419,900$133,574,368.54$13,141$629.86+$149.41MHPTO
5$1,419,456,383$1,259,577,089.13$14,408$846.81+$1419.44MHPTO
6$12,701,722,010$11,182,903,680.77$16,021$1,151.60+$12701.71MHPTO
7$107,112,319,794$93,521,477,242.90$18,122$1,588.22+$107112.30MHPTO
8$851,672,828,634$737,062,646,454.82$20,930$2,228.20+$851672.81MHPTO
9$6,388,431,809,242$5,477,141,882,604.03$24,792$3,191.91+$6388431.78MHPTO
10$45,232,126,160,142$38,396,504,124,252.64$30,274$4,689.40+$45232126.13MHPTO

HPTO vs JNJ: Complete Analysis 2026

HPTOStock

hopTo Inc., together with its subsidiaries, develops and sells application publishing software in the United States, Brazil, Japan, Germany, the Netherlands, and internationally. The company's application publishing software includes application virtualization and cloud computing software for a range of computer operating systems, including Windows, UNIX, and various Linux-based variants. It provides its application publishing software solutions under the GO-Global brand name. The company offers GO-Global, an application access solution that provides cross-platform remote access and Web-enabled access to existing software applications, as well as the deployment of secure and private cloud environments for use and/or resale by independent software vendors, corporate enterprises, governmental and educational institutions, and others. Its GO-Global software products comprise GO-Global for Windows that allows access to Windows-based applications from remote locations and Internet connections; GO-Global for UNIX, which allows access to UNIX and Linux-based applications from remote locations, and Internet and connections; and GO-Global Client that allows remote application access from various local, remote, and mobile platforms, including Windows, Linux, UNIX, Apple OS X and iOS, and Google Android. The company sells its products through resellers, such as original equipment manufacturers, system integrators, value-added resellers, and distributors. It serves small to medium-sized companies, departments within large corporations, governmental and educational institutions, and independent software vendors. The company was formerly known as GraphOn Corporation and changed its name to hopTo Inc. in September 2013. hopTo Inc. was incorporated in 1996 and is headquartered in Concord, New Hampshire.

Full HPTO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this HPTO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HPTO vs SCHDHPTO vs JEPIHPTO vs OHPTO vs KOHPTO vs MAINHPTO vs ABBVHPTO vs MRKHPTO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.